American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
MarketAxess Holdings
MKTX
|
+$259M |
| 2 |
Eli Lilly
LLY
|
+$211M |
| 3 |
Duke Energy
DUK
|
+$192M |
| 4 |
Colgate-Palmolive
CL
|
+$187M |
| 5 |
Labcorp
LH
|
+$168M |
Top Sells
| 1 |
Emerson Electric
EMR
|
+$252M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$246M |
| 3 |
Quest Diagnostics
DGX
|
+$218M |
| 4 |
Aflac
AFL
|
+$149M |
| 5 |
nVent Electric
NVT
|
+$129M |
Sector Composition
| 1 | Technology | 19.47% |
| 2 | Financials | 15.64% |
| 3 | Healthcare | 15.07% |
| 4 | Consumer Discretionary | 10.54% |
| 5 | Industrials | 10.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Riot Platforms
RIOT
$6.06B
| $127K | ﹤0.01% |
37,479
+26,299
| +235% | +$89.2K |
|
2377
Sangamo Therapeutics
SGMO
$160M
| $126K | ﹤0.01% |
40,239
+4,333
| +12% | +$13.6K |
|
2378
Editas Medicine
EDIT
$230M
| $124K | ﹤0.01% |
+14,023
| New | +$124K |
|
|
LICY
2379
DELISTED
Li-Cycle Holdings Corp.
LICY
| $123K | ﹤0.01% |
3,240
+1,573
| +94% | +$59.9K |
|
|
TIGR
2380
UP Fintech Holding
TIGR
$1.99B
| $123K | ﹤0.01% |
+36,001
| New | +$123K |
|
|
AZUL
2381
DELISTED
Azul
AZUL
| $121K | ﹤0.01% |
19,869
+6,437
| +48% | +$39.3K |
|
2382
Protagonist Therapeutics
PTGX
$3.59B
| $121K | ﹤0.01% |
+11,056
| New | +$121K |
|
2383
Equinox Gold
EQX
$8.4B
| $118K | ﹤0.01% |
35,980
-221,000
| -86% | -$723K |
|
|
BBBY
2384
DELISTED
Bed Bath & Beyond Inc
BBBY
| $114K | ﹤0.01% |
45,456
-262,570
| -85% | -$659K |
|
2385
Nurix Therapeutics
NRIX
$684M
| $113K | ﹤0.01% |
+10,332
| New | +$113K |
|
|
DSKE
2386
DELISTED
Daseke, Inc. Common Stock
DSKE
| $112K | ﹤0.01% |
+19,601
| New | +$112K |
|
2387
Zegna
ZGN
$2.26B
| $111K | ﹤0.01% |
+10,626
| New | +$111K |
|
|
KC
2388
Kingsoft Cloud Holdings
KC
$4.34B
| $109K | ﹤0.01% |
+28,496
| New | +$109K |
|
2389
Neuropace
NPCE
$320M
| $108K | ﹤0.01% |
72,508
-323,238
| -82% | -$482K |
|
2390
IonQ
IONQ
$13.1B
| $107K | ﹤0.01% |
+30,880
| New | +$107K |
|
2391
Bausch Health
BHC
$2.64B
| $106K | ﹤0.01% |
16,936
| – | – |
|
2392
Origin Materials
ORGN
$80.2M
| $106K | ﹤0.01% |
22,960
+7,870
| +52% | +$36.3K |
|
2393
Provident Bancorp
PVBC
$226M
| $105K | ﹤0.01% |
+14,409
| New | +$105K |
|
2394
Sutro Biopharma
STRO
$77.2M
| $104K | ﹤0.01% |
+12,823
| New | +$104K |
|
|
ALLK
2395
DELISTED
Allakos
ALLK
| $102K | ﹤0.01% |
+12,150
| New | +$102K |
|
2396
Sotera Health
SHC
$4.47B
| $102K | ﹤0.01% |
+12,243
| New | +$102K |
|
2397
Opko Health
OPK
$1.12B
| $99.9K | ﹤0.01% |
79,917
+27,616
| +53% | +$34.5K |
|
2398
MacroGenics
MGNX
$109M
| $99.3K | ﹤0.01% |
+14,792
| New | +$99.3K |
|
2399
Magnachip Semiconductor
MX
$110M
| $94.7K | ﹤0.01% |
+10,082
| New | +$94.7K |
|
2400
Medallion Financial
MFIN
$244M
| $94.5K | ﹤0.01% |
+13,238
| New | +$94.5K |
|